Phathom Pharmaceuticals (PHAT) Revenue (2023 - 2026)
Phathom Pharmaceuticals' (PHAT) quarterly Revenue came in at $58.3 million in Q1 2026, up 104.43% year-on-year from $28.5 million in Q1 2025, and up 1.25% on a QoQ basis from $57.6 million in Q4 2025.
Phathom Pharmaceuticals (PHAT) Revenue (2023 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has 4 years of Revenue data on file, last reported at $58.3 million in Q1 2026.
- On a quarterly basis, Revenue rose 104.43% year-over-year to $58.3 million in Q1 2026; TTM through Mar 2026 was $204.9 million, a 150.3% increase from a year earlier, with the FY2025 full-year figure at $175.1 million, up 216.93% from the prior year.
- Revenue for Q1 2026 stood at $58.3 million, up from $57.6 million in the prior quarter.
- Over the last five years, Revenue for PHAT reached as high as $58.3 million in Q1 2026 and fell as low as $682000.0 in Q4 2023.
- Historically, Revenue has averaged $28.9 million across 4 years, with a median of $29.1 million in 2024.
- Across the five-year window, Revenue surged 4249.56% in 2024 and jumped 94.12% in 2025, its largest moves.
- Year by year, Revenue stood at $682000.0 in 2023, then jumped by 4249.56% to $29.7 million in 2024, then surged by 94.12% to $57.6 million in 2025, then gained by 1.25% to $58.3 million in 2026.
- Per Business Quant data, the three most recent Revenue figures were $58.3 million in Q1 2026, $57.6 million in Q4 2025, and $49.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.56 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Phathom Pharmaceuticals | 951.79 Mn | 768.02 Mn | 46.31 Mn | 58.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.30 Mn |
| Dec 31, 2025 | 57.58 Mn |
| Sep 30, 2025 | 49.50 Mn |
| Jun 30, 2025 | 39.50 Mn |
| Mar 31, 2025 | 28.52 Mn |
| Dec 31, 2024 | 29.66 Mn |
| Sep 30, 2024 | 16.35 Mn |
| Jun 30, 2024 | 7.32 Mn |
| Mar 31, 2024 | 1.91 Mn |
| Dec 31, 2023 | 682,000.00 |